NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

Crimean–Congo hemorrhagic fever (CCHF ... its use in the early stage of the disease is recommended. A number of clinical and virological insights into CCHF have been revealed.

TAMA COUNTY — Chronic Wasting Disease (CWD) and Epizootic Hemorrhagic Disease (EHD) continue to impact Iowa’s deer population ...

Over the last several years, we have experienced an increase of large outbreaks of Crimean–Congo hemorrhagic fever virus in European countries and neighboring areas. This disease poses a great ...

These “hemorrhagic fever” symptoms are commonly ... on tests of more than a dozen samples collected so far. The latest disease outbreak in the Democratic Republic of Congo began on Jan ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

The latest disease outbreak in Congo began on Jan ... after three children ate a bat and died within 48 hours following hemorrhagic fever symptoms. There have long been concerns about diseases ...

Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the ...

The results, published in Science Translational Medicine on Feb. 19, could pave the way to the first treatment or vaccine for Crimean-Congo hemorrhagic ... s role in the disease was confirmed ...